Clinical Trial Update: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy and safety of odevixibat in children with biliary atresia who have undergone Kasai procedure; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Odevixibat (odevixibat)

Snippet

Sponsor: Albireo, an Ipsen Company | Conditions: Biliary Atresia | Phase 3 | Status: ACTIVE_NOT_RECRUITING